These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3868471)

  • 41. Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis.
    Umubyeyi AN; Martin A; Zissis G; Struelens M; Karita E; Portaels F
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):808-11. PubMed ID: 16848345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New derivatives of 2H-1,3-benzoxazine with anti-bacterial activity.
    Selleri R; Caldini O; Mura E; Rausa L; Cannizzaro G; Arena E; Persico D
    Arzneimittelforschung; 1965 Aug; 15(8):913-7. PubMed ID: 5898647
    [No Abstract]   [Full Text] [Related]  

  • 43. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
    Peddie BA
    N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
    [No Abstract]   [Full Text] [Related]  

  • 44. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
    Lipsky BA; Holroyd KJ; Zasloff M
    Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 48. Antibacterial action of honey on oral streptococci.
    Basson NJ; du Toit IJ; Grobler SR
    J Dent Assoc S Afr; 1994 Jul; 49(7):339-41. PubMed ID: 9508952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First International Symposium on Ofloxacin. Proceedings. Mainz, 27-28 November 1986.
    Drugs; 1987; 34 Suppl 1():1-187. PubMed ID: 3481310
    [No Abstract]   [Full Text] [Related]  

  • 51. Ofloxacin and antacids.
    Maesen FP; Davies BI; Geraedts WH; Sumajow CA
    J Antimicrob Chemother; 1987 Jun; 19(6):848-50. PubMed ID: 3475268
    [No Abstract]   [Full Text] [Related]  

  • 52. A new synthesis of 7H-pyrido[1,2,3-de][1,4]benzoxazine derivatives including an antibacterial agent, ofloxacin.
    Egawa H; Miyamoto T; Matsumoto J
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4098-102. PubMed ID: 3470155
    [No Abstract]   [Full Text] [Related]  

  • 53. Penetration of ofloxacin into nasal tissues.
    Tolsdorff P
    Infection; 1993; 21(1):66-70. PubMed ID: 8449587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. International experiences with ofloxacin, a new quinolone.
    Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Monk JP; Campoli-Richards DM
    Drugs; 1987 Apr; 33(4):346-91. PubMed ID: 3297617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacokinetic and clinical study of ofloxacin, a new antibacterial effective agent].
    Aderhold L; Frenkel G
    Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(5):394-7. PubMed ID: 3868471
    [No Abstract]   [Full Text] [Related]  

  • 58. [The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].
    Seibert G; Klesel N; Limbert M; Schrinner E; Winkler I
    Arzneimittelforschung; 1984; 34(11):1552-4. PubMed ID: 6596953
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.